These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 26857878

  • 1. The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy.
    Tucker PE, Bulsara MK, Salfinger SG, Tan JJ, Green H, Cohen PA.
    Maturitas; 2016 Mar; 85():42-8. PubMed ID: 26857878
    [Abstract] [Full Text] [Related]

  • 2. Sexuality and quality of life in women with a prior diagnosis of breast cancer after risk-reducing salpingo-oophorectomy.
    Tucker PE, Saunders C, Bulsara MK, Tan JJ, Salfinger SG, Green H, Cohen PA.
    Breast; 2016 Dec; 30():26-31. PubMed ID: 27592287
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy.
    Tucker PE, Bulsara MK, Salfinger SG, Tan JJ, Green H, Cohen PA.
    Gynecol Oncol; 2016 Jan; 140(1):95-100. PubMed ID: 26545955
    [Abstract] [Full Text] [Related]

  • 4. Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy.
    Stuursma A, van Driel CMG, Wessels NJ, de Bock GH, Mourits MJE.
    Maturitas; 2018 May; 111():69-76. PubMed ID: 29673834
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy.
    Tucker PE, Cohen PA.
    Int J Gynecol Cancer; 2017 May; 27(4):847-852. PubMed ID: 28333842
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
    Wei X, Oxley S, Sideris M, Kalra A, Brentnall A, Sun L, Yang L, Legood R, Manchanda R.
    Am J Obstet Gynecol; 2023 Oct; 229(4):388-409.e4. PubMed ID: 37059410
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer.
    Heiniger L, Butow PN, Coll J, Bullen T, Wilson J, Baylock B, Meiser B, Price MA.
    Fam Cancer; 2015 Mar; 14(1):105-15. PubMed ID: 25283514
    [Abstract] [Full Text] [Related]

  • 11. Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy.
    Johansen N, Liavaag AH, Tanbo TG, Dahl AA, Pripp AH, Michelsen TM.
    Gynecol Oncol; 2016 Jan; 140(1):101-6. PubMed ID: 26597462
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
    Hall E, Finch A, Jacobson M, Rosen B, Metcalfe K, Sun P, Narod SA, Kotsopoulos J.
    Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
    [Abstract] [Full Text] [Related]

  • 14. Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.
    Steenbeek MP, Harmsen MG, Hoogerbrugge N, de Jong MA, Maas AHEM, Prins JB, Bulten J, Teerenstra S, van Bommel MHD, van Doorn HC, Mourits MJE, van Beurden M, Zweemer RP, Gaarenstroom KN, Slangen BFM, Brood-van Zanten MMA, Vos MC, Piek JMJ, van Lonkhuijzen LRCW, Apperloo MJA, Coppus SFPJ, Massuger LFAG, IntHout J, Hermens RPMG, de Hullu JA.
    JAMA Oncol; 2021 Aug 01; 7(8):1203-1212. PubMed ID: 34081085
    [Abstract] [Full Text] [Related]

  • 15. Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.
    Gaba F, Robbani S, Singh N, McCluggage WG, Wilkinson N, Ganesan R, Bryson G, Rowlands G, Tyson C, Arora R, Saridogan E, Hanson H, Burnell M, Legood R, Evans DG, Menon U, Manchanda R, PROTECTOR team.
    Int J Gynecol Cancer; 2021 Feb 01; 31(2):286-291. PubMed ID: 32907814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
    Johansen N, Liavaag AH, Iversen OE, Dørum A, Braaten T, Michelsen TM.
    Acta Obstet Gynecol Scand; 2017 May 01; 96(5):547-555. PubMed ID: 28236297
    [Abstract] [Full Text] [Related]

  • 20. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.
    Finch A, Metcalfe KA, Chiang J, Elit L, McLaughlin J, Springate C, Esplen MJ, Demsky R, Murphy J, Rosen B, Narod SA.
    Psychooncology; 2013 Jan 01; 22(1):212-9. PubMed ID: 21913283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.